Timothy Walbert is the Chairman of the Board, President, and Chief Executive Officer of Horizon Therapeutics. Before joining Horizon, he was the President, Chief Executive Officer, and Director of IDM Pharma Inc., a public biopharmaceutical company which was acquired by Takeda America Holdings Inc., or Takeda, in June 2009. At the Executives’ Club of Chicago, Walbert discussed his personal journey and growth of Horizon, the importance of engaging with and establishing a connection with local communities and the key role that businesses play in laying the groundwork to prop up underserved communities who lack necessary resources to thrive.